Establishment of diagnostic reference levels in cardiac computed tomography by Rawashdeh, Mohammad et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Establishment of diagnostic reference levels in cardiac computed
tomography
Author(s) Rawashdeh, Mohammad; Saade, Charbel; Zaitoun, Maha; Abdelrahman,
Mostafa; Brennan, Patrick; Alewaidat, Haytham A.; McEntee, Mark F.
Publication date 2019-08-30
Original citation Rawashdeh, M., Saade, C., Zaitoun, M., Abdelrahman, M., Brennan, P.,
Alewaidat, H. and McEntee, M. F. 'Establishment of diagnostic
reference levels in cardiac computed tomography', Journal of Applied
Clinical Medical Physics, (7pp.) [In Press]. DOI: 10.1002/acm2.12711





Access to the full text of the published version may require a
subscription.
Rights © 2019 The Authors. Journal of Applied Clinical Medical Physics
published by Wiley Periodicals, Inc. on behalf of American
Association of Physicists in Medicine.  This is an open access article
under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium,







MED I C A L I MAG I N G
Establishment of diagnostic reference levels in cardiac
computed tomography
Mohammad Rawashdeh1 | Charbel Saade2 | Maha Zaitoun1 | Mostafa Abdelrahman1 |
Patrick Brennan3 | Haytham Alewaidat1 | Mark F. McEntee4
1Faculty of Applied Medical Sciences,
Jordan University of Science and
Technology, Irbid, Jordan
2Department of Diagnostic Radiology,
American University of Beirut Medical
Center, Beirut, Lebanon
3Faculty of Health Sciences, Medical Image
Optimization and Perception Group
(MIOPeG), and the Brain and Mind Centre,
The University of Sydney, Sydney, NSW,
Australia
4Discipline of Diagnostic Radiography, UG
12 Aras Watson, Brookfield Health
Sciences, University College Cork, College
Road, Cork, Ireland









The aim of this study was to determine diagnostic reference levels (DRLs) for car-
diac computed tomography (CCT) in Jordan. Volume computed tomography dose
index (CTDIvol) and dose–length product (DLP) were collected from 228 CCTs per-
formed at seven Jordanian hospitals specialized in cardiac CT. DRLs for cardiac CT
were defined at the 75th percentile of CTDIvol and DLP. CTDIvol and DLP were col-
lected from 30 successive cardiac CT in each center except for one center (18
scans). The 75th percentile of the CTDIvol and the DLP of the centers calculated
from mixed retrospective and prospective gated modes were 47.74 milligray (mGy)
and 1035 mGy/cm, respectively. This study demonstrated wide dose variations
among the surveyed hospitals for cardiac CT scans; there was a 5.1‐fold difference
between the highest and lowest median DLP with a range of 223.2–1146.7 mGy/
cm. Differences were associated with variations in the mAs and kVp. This study
confirmed large variability in CTDIvol and DLP for cardiac CT scans; variation was
associated with acquisition protocols and highlights the need for dose optimization.
DRLs are proposed for CCT; there remains substantial potential for optimization of
cardiac CT examinations for adults in Jordan.
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1 | INTRODUCTION
Radiation doses differ between hospitals for standard‐sized patients
undergoing the same examination.1 These dose variations are “pri-
marily attributable to local choices regarding technical parameters,
rather than patient, institution, or machine characteristics.” Com-
puted tomography (CT) has a large range of scanning options that
lead to a large variation in patient radiation doses. Several factors
affect radiation dose to patients undergoing cardiac computed
tomography (CCT) procedures.2 Concerns have been raised about
the radiation exposure of CCT. Recently, prospective gated mode
(PGM) was developed to reduce radiation dose. PGM, also known
as “step‐and‐shoot” or “sequential scan mode,”3 has been devel-
oped as an alternative mode to standard helical (spiral) scanning
with retrospective electrocardiographic gating with the aim of
decreasing radiation dose during CCT to patients with stable heart
rates. Previous work by other authors has identified key contribu-
tors to variations in dose as radiographic settings, equipment fac-
tors, the level of quality assurance in place, radiographer training,
radiographer experience, as well as patient body habitus.4,5 Dose
optimization requires identification of which factors are the great-
est contributor to variations in dose. Once the contribution of fac-
tors is established, operators can consider corrective action in a
cost‐effective manner.4
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In order to achieve optimization, guidance on appropriate levels
of patient exposure is required. Basic safety standards have been
provided by the International Commission on Radiological Protection
(ICRP), World Health Organization (WHO), and International Atomic
Energy Agency (IAEA) in order to optimize the protection of patients
during all radiological procedures, including CT.6 These include a rec-
ommendation for DRLs7 or guidance levels to be put in place, moni-
tored, and used to improved radiological procedures.8 DRLs enhance
patient protection and allow comparisons of the radiation dose of
different CT systems, and procedures. DRLs offer a framework
where dose levels from different hospitals can be compared and
when DRLs are exceeded by a department, corrective strategies can
be taken.
DRLs are not dose limits, but rather guidelines. Where they are
regularly exceeded, corrective action should be taken. DRLs have
been effective in reducing radiation dose, with radiation levels
being reduced by 50% in the UK since their adoption.9,10 As dose
variation for the same examination can reach up to 23‐fold
between centers for non‐CT X‐ray examinations2 and 13‐fold for
CT examinations.11 Strategies such as DRLs are required to reduce
dose variation between centers. The method of establishing DRLs
starts with a determination of radiation dose levels delivered for
specific examinations in several hospitals in an individual country
(or state). These data are then used to compute examination‐speci-
fic DRLs for that country, state or region, usually in terms of the
75th percentile of the dose distribution. Due to the differing eth-
nicities, procedures, and equipment across different countries, it is
advisable that each country determine their own DRLs. While the
requirement for DRLs have been described in legislative documents
in Jordan and internationally, and their implementation for general
examinations is seen in Europe and the US, national DRL values do
not exist for cardiac CT examinations in Jordan. Cardiac CT exami-
nations are among the highest dose examinations, with patients
undergoing chest CT having doses ranging from 4 to 18 mSv but
those undergoing cardiac CT receiving 5–32 for a coronary CT
angiogram, and 12–18 mSv for a 64‐slice coronary CT Angiography
(CTA) with tube modulation. However, with good technique, a
prospectively triggered coronary CTA patient can receive 2–
4 mSv.12 The dose for cardiac CT in Jordan is currently not known,
so we cannot compare our performance internally or internation-
ally. The current work aims to address this gap.
2 | MATERIALS AND METHODS
In 2018, a retrospective survey was performed across seven Jorda-
nian hospitals that routinely perform CCT. Data from 228 cardiac CT
scans were collected over a 3‐month period from May to August.
These cardiac CT scans were performed on a wide range of scanners
with different number of slices from three manufacturers (GE, Sie-
mens, and Philips). These are representative of CT scanners being
used across Jordan. According to the Jordanian regulations, CT scan-
ners undergo a quality control program that includes daily, monthly,
quarterly, and annual checking of the assessment of the radiation
dose.13
Dose in CTDIvol and DLP was provided in 30 successive car-
diac CT scans in each center except for one, which provided 18
scans. There survey respondents used two scanning modes,
prospective electrocardiographic (ECG) gating modes (PGM) where
the scanner monitors the patient's ECG and retrospective ECG‐gat-
ing modes (RGM) where the patient is scanned continuously, while
only certain portions of the scan are used to reconstruct the
image. Participants were all adults between 17 to 75 yr and all
genders were included. In line with a methodology previously pub-
lished,9,14 protocol and scan sequence details were grouped in the
survey (Table 1). A clinical coordinator with CT experience was
appointed in each center to administer and receive the question-
naires. The survey focused on CTA performed for the assessment
of coronary artery disease. CTA included one single scan per
examination. Calcium scoring, evaluation bypass graft patency and
preparation of trans catheter aortic valve implantation were
excluded.
To standardize weight for the sampled population and in line
with international recommendations, the survey included only those
patients who weighed between 60 and 80 kg.9
2.A | Radiation dose data
On modern CT scanners CTDIvol and DLP are provided for every
sequence and examination. However, on older equipment it was
necessary to calculate the dose using exposure and procedural data.
The patient dose data, CTDIvol and DLP values, were extracted from
the picture archiving and communication system (PACS). A summary
of the two relevant dose parameters is given below along with
methods for calculating these factors. CTDIvol is defined as weighted
CTDI (CTDIw) divided by CT pitch and provide an estimation for
average phantom dose for a complete spiral CT scan.15
2.B | Weighted CT Dose Index — CTDIw
This describes the radiation dose delivered per unit cranio–caudal (z)
axis thickness. Significant previous work has provided methodologies
so that the baseline dose value CTDIw can be calculated for specific
examinations and from this baseline value other important dose met-
rics can be calculated4,7,16–22 and these are explained below. Using
typical CTDIw values calculated from a dosimetry phantom for each
CT scanner model, with specific exposure factors, the IMPACT
group14 has provided a calculator from which CTDIw can be calcu-
lated for any sequence, for any model using a range of exposure fac-
tors. This calculation is shown in Formula 1.
CTDIw mGyð Þ ¼ nCTDIwð Þscanner;phantom;kV;NT FNTð ÞscannerC (1)
where (n CTDIw)scanner, phantom, kV, NxT is a coefficient based on the
normalized dose [CTDIw for a specific scanner at a particular kV,
slice number (N), and thickness (T)]; (FNxT)scanner are dose coefficients
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for all other slice number and thicknesses; C is the mAs or effective
mAs if pitch correction was included
2.C | Volumetric CT dose index ‐ CTDIvol
Since CTDIw does not consider whether axial slices are contiguous,
noncontiguous, or overlapping, a “pitch” correction must be added
which provides a more representative volume CTDI or CTDIvol (For-
mula 2).
CTDIvol mGyð Þ ¼ CTDIwPitch factor (2)
where pitch factor is the distance the table moves in the z axis
divided by the slice number and each slice thickness.
CTDIw is calculated from Formula 1.
2.D | Dose Length Product (DLP)
The dose measurements above do not consider the total length of
the patient who has been irradiated during each examination
sequence. This is calculated using Formula 3.
DLP mGy  cmð Þ ¼ CTDIvol  Scan length (3)
where CTDIvol is calculated from Formula 2.
2.E | Data analysis
The minimum, maximum, and the first, second, and third quartiles
were calculated for CTDIvol, and DLP using Statistical Package for
the Social Sciences (SPSS) software (SPSS for Windows, version
22.0, SPSS Inc.). Stepwise regressions were performed to find which
exposure factors were associated with high dose and the level of
contribution of each factor. The following factors were included:
kVp, mAs, pitch, slice thickness, and number of slices. In addition,
international DRLs were compared to the current national DRL level
established in the current work.
3 | RESULTS
Seven hospitals (four public, one university, and two private) partici-
pated in the study. Recordings from a total of 228 CCT examinations
were collected, of which 60 CCT were performed using PGM and
168 using RGM. Sixty‐one percent of patients were males and 39%
were females and the mean weight for both of them was 70.1 kg
(Min = 60; Max = 80, SD = 8.93). Data were collected from seven
scanners, of which two and five centers acquired image data in 256
and 128 slices. This represents approximately 31% of cardiac CT
units in Jordan and exceeds the sample sizes used previously to
establish reference levels in other countries.5,7 A sample size calcula-
tion indicated a difference <5% in dose would be detected at 0.8
power. Patient and equipment characteristics and cardiac CT proto-
cols are shown in Table 2. A summary of DRLs per scan mode
(PGM, RGM, and Mixed Modes) and per center is shown Table 3.
The mean CTDIvol and DLP per CCT examination were calculated
for each site and used to compare doses across CCT centers
(Table 4). Wide variations were found between hospitals surveyed,
with 1‐ to 5.1‐fold differences in mean CTDIvol and DLP reported for
the examinations surveyed.
Comparisons of the findings with DRLs published from other
countries are shown in Table 5.18‐24
Multiple regression analysis for the Mixed Modes suggested that
mAs, kVp, and number of slices were more accurately predictive of
CTDIvol than any individual variable alone, with R
2 of 0.530
(P ≤ 0.001). The results of the regression also showed that combina-
tion of mAs, kVp, and number of slices could significantly predicate
DLP. All factors had a significant positive predictor value, with a
TAB L E 1 Information about the scanners in each hospital.
Hospital Manufacturer Year of manufacture CT model type Year of installation Gantry rotation Capacity (slice No.)
A Philips 2008 Brilliance ICT scan 256 2011 360 256
B Siemens 2014 Somatom force 2016 360 384
C Philips 2010 Philips multislices 64p/s 2010 360 65
D Siemens 2010 Multislices 128 2011 360 128
E Siemens 2006 Somatom sensation 64 2006 360 64
F GE 2011 Optima 99 multislice 2012 360 180
G Siemens 2008 Somatom sensation 64 dual Source 2008 360 128
TAB L E 2 Patients and equipment's characteristics and cardiac
computed tomography (CT) protocols (n = 228).




Age (years) 50.72 (41–61)
Weight (kg) 70.1 (66.2–80.0)







GE Optima 99 31 (13.6%)
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comparatively low R2 of 0.364 (P ≤ 0.001). The equations were
CTDIvol ¼ 72:00þ 0:03Aþ 0:800B 0:013C
where A is mAs, B is kVp, and C is the number of slices.
DLP ¼ 1352:19þ 0:549Aþ 16:794B 0:233C
where A is mAs, B is kVp, and C is the number of slices.
In the PGM mode, the results from the multiple linear regres-
sions demonstrated that mAs was more accurately predictive of
CTDIvol than any other variable, with R
2 of 0.646 (P ≤ 0.001), while
for the case of the DLP, kVp, number of slices, and mAs could signif-
icantly predicate DLP, with R2 of 0.820 (P ≤ 0.001), which is signifi-
cantly higher (Table 6).
CTDIvol ¼ 8:238þ 0:070A
where A is mAs
DLP ¼ 1475:37þ 17:685A 1:049Bþ 0:750C
where A is kVp, B is the number of slices, and C is mAs
For the RGM mode, the results from the multiple linear regres-
sions demonstrated that kVp, pitch, mAs, number of slices, and slice
thickness were the predictive factors of CTDIvol, with R
2 of 0.635
(P ≤ 0.001), while mAs, kVp, and number of slices were the predic-
tive factors of DLP with R2 of 0.268 (P ≤ 0.001), which is relatively
lower as demonstrated in the following two formulas.
CTDIvol ¼57:091þ0:908A30:433Bþ0:023C0:011D4:307E
where A is kVp, B is pitch, C is mAs, D is the number of slices, and
E is the slice thickness.
DLP ¼ 1244:8þ 0:417Aþ 17:03B 0:228C
where A is mAs, B is kVp, and C is the number of slices.
4 | DISCUSSION
DRLs were first proposed by the International Commission on Radio-
logical Protection in 1991. They are defined as “dose levels in radio
diagnostic practices for typical examinations for patient groups or
standard phantoms for broadly defined groups of equipment.”9,25,26
Patient radiation doses that exceed established DRLs should be
investigated to identify potential reasons for higher dose and to
allow better management of the radiation dose of similar procedures
in the future.21,27 With the significant amount of studies that have
been conducted to establish the DRL levels in other countries and in
the different CT scans,4,7,16–22 this is the first study to establish
DRLs in CCT in Jordan.
Research to date has demonstrated a maximum potential dose
reduction in CT scan between 60% and 80%.28–31 However, it is
important to appropriately balance the need to achieve low radiation
dose with the likelihood of creating useful diagnostic CT images.
Low radiation exposure for a certain patient during CCT scan may
result high image noise; however, it needs to be acknowledged that
while high radiation exposure may increase image quality and reduce
image noise, this does not automatically mean additional diagnostic
information.32 The current work highlighting wide dose variations for
TAB L E 3 Diagnostic reference levels (DRLs) for mixed, prospective
gating mode (PGM), and respective gating modes (RGM) cardiac
computed tomography (CT) scans in Jordan.
Scan type Mixed modes PGM (n = 60) RGM (n = 168)
CTDIvol
Minimum 2.00 2.00 6.60
25th 13.71 4.50 21.00
Median 31.93 7.84 40.42
75th 47.74 33.37 64.54
Maximum 86.64 33.80 86.64
DLP
Minimum 27.60 27.60 216.00
25th 329.58 151.80 431.97
Median 727.00 626.60 888.30
75th 1035.00 692.95 1141.50
Maximum 2865.00 740.00 2865.00
TAB L E 4 Diagnostic reference levels (DRLs) for cardiac computed tomography (CT) scans performed with Mixed Modes per center.
Center 1 (n = 30) 2 (n = 45) 3 (n = 29) 4 (n = 45) 5 (n = 18) 6 (n = 31) 7 (n = 30)
CTDIvol
Minimum 7.84 24.06 21.0 4.50 13.55 2.63 2.0
25th 10.78 38.85 31.93 4.50 13.55 64.54 5.80
Median 12.69 43.89 64.54 9.90 18.37 64.54 19.59
75th 19.15 47.87 79.43 33.80 22.30 64.54 21.70
Maximum 44.73 79.43 86.64 33.80 22.30 64.56 21.9
DLP
Minimum 146.90 385.00 583.9 151.80 329.58 35.50 27.60
25th 189.10 807.40 831.20 618.10 329.58 1126.20 140.00
Median 223.20 888.30 1035.00 653.60 431.97 1146.70 251.05
75th 583.90 934.60 1435.00 726.50 1267.07 1236.80 293.00
Maximum 933.40 1441.90 1549.00 740.00 1267.07 1356.10 2865.00
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cardiac CT scans were shown across hospitals. With a range of
223.2–1146.7 mGy cm, the highest mean DLP was 5.1 times higher
than the median value. These differences were primarily attributable
to local choices regarding technical parameters, rather than patient,
institution, or machine characteristics. Changes in CTDIvol were asso-
ciated with variations in the mAs, kVp pitch, and slice thickness.
Multiple regression analysis predicted that low DLP was most
dependent on mAs, kVp, mode of scan, and number of slices.
The current study reports that PGM allowed a significant dose
reduction with CTDIvol of 60.4% compared with the RGM mode.
These wide dose variations between modes emphasize the need to
analyze the CTDIvol and DLP individually and, therefore, establish
DRL for each mode.22 The current work did not compare the diag-
nostic performance of PGM with RGM. However, the reduction in
radiation dose with PGM scanning was larger than the effect of
other radiation dose‐reduction techniques. The 75th DLP in scanned
average‐sized patients was only 692.95 mGy cm. Among those cen-
ters using PGM, the lowest median DLP was 223.2 mGy cm in Cen-
tre A, this dose was in contrast with 75th DLP of RGM
1146.60 mGy cm. This finding supports the use of PGM as an effec-
tive tool in comprehensive radiation dose‐reduction technique. The
current work shows that a reduction of 26.3% in the DLP in CT
scanning within participating centers is achievable with PGM, this is
a larger decrease in dose than reported in other works.2,19,22
Compared with nationwide surveys from other countries, Jorda-
nian CCT centers generally appear to employ higher doses than
those countries previously surveyed; therefore, there is a large
potential for optimization of CCT examinations for adults in Jordan.
Variation in radiation dose shown in the current work highlights the
need for the adoption of DRLs that radiologists or radiographers
need to optimize their CCT protocols and that interest in dose opti-
mization must be improved. The work also demonstrates the need
for periodic reassessment of DRLs at short‐time intervals. Clinical
audits should also identify further causal agents, eliminate unjustified
examinations, and optimize procedures.
Further work should investigate size‐specific dose estimate
(SSDE). SSDE accounts for patient parameters establishment of DRLs
and removes the requirement to limit the average of the sample to
between 60 and 80 kg. Additional studies should to be conducted
on the SSDE application to DLP so that scan length can be consid-
ered for in the equation of patient dose.
There are several noteworthy limitations to our study. First, as
our analysis was retrospective, we could not obtain information on
several parameters that possibly influence the radiation dose such as
beam collimation, rotation time, and patients' diameter. Second, we
did not assess the CT scan indications; hence, the parameters of
these CT scans may not represent the routine protocols of the
TAB L E 6 Predictive of CTDIvol, and dose–length product (DLP)
from exposure factors using stepwise regression factors for Mixed
























Number of slices 0.625 ≤0.001




Number of slices 0.268 ≤0.001
TAB L E 5 Cardiac computed tomography (CT) diagnostic reference levels (DRLs) in Jordan compared with other international cardiac CT DRLs.
Iran18 France19 Italy23 Netherlands20 Japan21 Switzerland24 KSA22 Jordan (current study)
CTDIvol
Mixed 66.5 – 61 – – 50 – 47.74
PGM – 26 – – – – 29 33.37
RGM – 44 – – – – 43 64.54
DLP
Mixed 1073 – 1208 671 1510 1000 – 1035.0
PGM – 370 – – – – 343 692.95
RGM – 870 – – – – 808 1141.50
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respective institutions. Third, since our analysis was conducted on
only seven institutions, bias could have been introduced, even
though the CT scans we obtained were from various centers geo-
graphically dispersed throughout Jordan.
This study demonstrates large variability in CTDIvol and DLP dur-
ing CCT examinations in Jordan and highlights the need for doses to
be reduced. PGM is clearly an effective dose‐reduction technique for
cardiac CT examinations and the use of this mode should be encour-
aged. Local DRL results should be communicated back to each CT
center to encourage optimization of scan parameters and develop
more proactive comparisons with national DRL and other CT
centers.
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